At the recent forum “Improving Access to Affordable Cancer Treatments in Malaysia”, the issue of treatment costs was discussed by panellists from the Ministry of Health (MOH) and pharmaceutical industry representatives.
Long-term results of the POET* trial have suggested that patients with left-sided infective endocarditis (IE) could safely switch from conventional intravenous (IV) antibiotics to oral antibiotics, with oral antibiotics associated with a reduced mortality risk.
Extensive coronary artery calcium (CAC ≥1,000) in patients corresponds to a very high-risk phenotype that is associated with mortality outcomes equal to high-risk patients treated for secondary prevention of cardiovascular disease (CVD), reports a study presented at the American College of Cardiology (ACC) Annual Scientific Sessions 2019.
Following a low-carbohydrate diet to shed excess pounds may be bad for the heart, such that individuals consuming low levels of carbohydrates are at increased risk of developing atrial fibrillation, according to a study presented at the American College of Cardiology Annual Scientific Session 2019.
In intravenous drug users, hospital admissions for infective endocarditis (IE) appear to be on the rise, with the prevailing treatment approach shifting away from surgical to medical, according to a new study presented at the recently concluded 68th Annual Scientific Session & Expo of the American College of Cardiology (ACC 2019).
Icosapent ethyl – a prescription and highly purified version of the omega-3 fatty acid, eicosapentaenoic acid (EPA) – takes the spotlight in REDUCE-IT* as it markedly reduced the rate of total ischaemic events in individuals with high cardiovascular (CV) risk**.
A recent study by the Hong Kong Polytechnic University (HKPU) indicates that acupuncture may be effective for treating sleep problems in patients with Parkinson’s disease. Meanwhile, investigators from the Chinese University of Hong Kong (CUHK) have uncovered a possible explanation for the cognitive impairment experienced by patients with Parkinson’s disease.
The fully human monoclonal antibody secukinumab triumphed over ustekinumab once again in patients with moderate-to-severe plaque psoriasis, according to the phase IIIb CLARITY* trial presented at the recent annual meeting of the American Academy of Dermatology (AAD 2019).
A Singapore study has shown that the muscle-sparing modification of the pedicled transverse rectus abdominis myocutaneous (MS-TRAM) flaps is on a par with conventional TRAM flap. The pedicled MS-TRAM preserves innervated muscle in the donor site, reducing time to ambulation and postoperative pain.
A subgroup of patients with HBeAg-negative chronic hepatitis B virus (HBV) infection who ceased their long-term nucleotide analogue treatment maintained virological suppression, pointing to a group of patients who may be suitable for treatment cessation, according to a recent study.
Use of mirabegron in the treatment of men with overactive bladder (OAB) appears to effectively alleviate urgency and storage symptoms, but not reduce the frequency of micturition episodes, according to data from the MIRACLE study.